LoginRegister
    Zydus Cadila gets USFDA nod to Potassium Chloride ER Capsules to prevent hypokalemiaZydus Cadila gets USFDA nod to Potassium Chloride ER Capsules to prevent hypokalemia
    Central Drug Regulator directs states, UTs to ban sale, manufacture, ad of e cigarettesCentral Drug Regulator directs states, UTs to ban sale, manufacture, ad of e cigarettes
    Seres Therapeutics, Astrazeneca to collaborate on microbiome immuno oncologySeres Therapeutics, Astrazeneca to collaborate on microbiome immuno oncology
    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019
    Laurus Labs gets USFDA nod to Hydroxychloroquine tablets for treating malariaLaurus Labs gets USFDA nod to Hydroxychloroquine tablets for treating malaria
    Pfizer biosimilar to Roche Herceptin wins USFDA nodPfizer biosimilar to Roche Herceptin wins USFDA nod
    USFDA approves use of Regeneron, Sanofi eczema drug Dupixent in adolescentsUSFDA approves use of Regeneron, Sanofi eczema drug Dupixent in adolescents
    Integra Lifesciences Boston plant gets USFDA warning letterIntegra Lifesciences Boston plant gets USFDA warning letter
    Opioid litigation concerns weigh on pharmaceutical loan borrowersOpioid litigation concerns weigh on pharmaceutical loan borrowers
    Landmark: JnJ told to pay Rs 74.5 lakh to patient by CDSCOLandmark: JnJ told to pay Rs 74.5 lakh to patient by CDSCO
    Banks agree to one time settlement with Sterling Biotech with 65 percent haircutBanks agree to one time settlement with Sterling Biotech with 65 percent haircut
    Unichem Labs Ghaziabad facility successfully completes USFDA inspectionUnichem Labs Ghaziabad facility successfully completes USFDA inspection
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X